Introduction: Malaria remains one of the most important infectious diseases, causing around
655 000 deaths annually, mostly among children in Sub-Saharan Africa. Plasmodium …

Over the last 5 years, there has been an increased investment in malaria medicines, with the
emergence of a range of new fixed dose artemisinin combination therapies (FACTs). Of the …

Malaria continues to be a major threat in the developing world, with> 1 million clinical
episodes and 3000 deaths every day. In the last century, malaria claimed between 150 and …

Introduction Malaria, the most devastating parasitic disease, is currently treated with
artemisinin-based combination therapies (ACTs). Unfortunately, some ACTs are unable to …

Introduction: Chemotherapy of malaria has become a rapidly changing field. Less than two
decades ago, treatment regimens were increasingly bound to fail due to emerging drug …

Malaria is a disease caused by parasitic protozoa of the genus Plasmodium. Despite
significant advances in understanding the disease and the parasite biology, malaria still …

Malaria is still today one of the deadliest infectious diseases affecting a huge proportion of
the world population, hitting with special virulence those people living in the least developed …

Parasitic infections due to the protozoa Plasmodium are responsible for malaria, a severe
disease that still caused about 225 million cases and 781,000 human deaths in 2009 …

Malaria kills an estimated one million people a year--mostly children under 5. State-of-the-
art medicines known as artemisinin combination therapies (ACTs) are available, and …

Despite considerable advances in the treatment and prevention of malaria, Plasmodium
falciparum is still a threat to millions of people across the world, particularly in sub‐Saharan …